investorscraft@gmail.com

Intrinsic Value of Colgate-Palmolive Company (CL)

Previous Close$92.78
Intrinsic Value
Upside potential
Previous Close
$92.78

VALUATION INPUT DATA

This valuation is based on fiscal year data as of 2024 and quarterly data as of .

Data is not available at this time.

Stock Valuation Context

Business Model And Market Position

Colgate-Palmolive Company operates as a global leader in the consumer goods sector, specializing in oral care, personal care, home care, and pet nutrition. The company generates revenue primarily through the sale of branded products such as Colgate toothpaste, Palmolive dish soap, and Hill’s pet food, distributed across retail and e-commerce channels. Its diversified portfolio and strong brand equity position it competitively in both developed and emerging markets. Colgate-Palmolive leverages extensive R&D capabilities and a robust supply chain to maintain innovation leadership, particularly in oral hygiene, where it holds a dominant market share. The company’s strategic focus on premiumization and sustainability aligns with evolving consumer preferences, reinforcing its resilience against private-label competition. With a presence in over 200 countries, Colgate-Palmolive benefits from geographic diversification, though it faces pricing pressures in inflationary environments. Its market position is further strengthened by long-standing retailer relationships and targeted marketing investments.

Revenue Profitability And Efficiency

Colgate-Palmolive reported FY 2024 revenue of $20.1 billion, with net income of $2.89 billion, reflecting a net margin of approximately 14.4%. Diluted EPS stood at $3.51, supported by disciplined cost management and pricing actions. Operating cash flow of $4.11 billion underscores efficient working capital management, while capital expenditures of $561 million indicate moderate reinvestment needs relative to cash generation.

Earnings Power And Capital Efficiency

The company demonstrates consistent earnings power, with operating cash flow covering capital expenditures by a wide margin. Its ability to generate $4.11 billion in operating cash flow against $561 million in capex highlights strong capital efficiency. This allows for sustained dividends and share repurchases, though debt levels warrant monitoring given $8.51 billion in total debt.

Balance Sheet And Financial Health

Colgate-Palmolive maintains a solid balance sheet with $1.1 billion in cash and equivalents, though its $8.51 billion total debt suggests a leveraged position. The company’s investment-grade credit rating and stable cash flows mitigate liquidity risks. Shareholders’ equity remains healthy, supporting continued dividend payments and strategic flexibility.

Growth Trends And Dividend Policy

Organic growth has been steady, driven by pricing and innovation in core categories. The company’s dividend policy is robust, with a $2.19 annual dividend per share, reflecting a commitment to returning capital to shareholders. Long-term growth hinges on emerging market expansion and premium product adoption, though volume growth remains challenged in mature markets.

Valuation And Market Expectations

At a diluted EPS of $3.51, Colgate-Palmolive trades at a premium valuation relative to peers, reflecting its defensive qualities and consistent cash flow. Market expectations are anchored to mid-single-digit revenue growth and margin stability, with investor focus on the company’s ability to navigate cost inflation and currency headwinds.

Strategic Advantages And Outlook

Colgate-Palmolive’s strategic advantages include its global brand recognition, innovation pipeline, and distribution scale. The outlook remains stable, with growth initiatives in oral care and pet nutrition offsetting slower categories. Risks include commodity cost volatility and competitive pressures, but the company’s pricing power and cost controls provide resilience.

Sources

10-K filing, company investor relations

show cash flow forecast

FINANCIAL STATEMENTS FORECAST and PRESENT VALUE CALCULATION

Fiscal year2025202620272028202920302031203220332034203520362037203820392040204120422043204420452046204720482049

INCOME STATEMENT

Revenue growth rate, %NaN
Revenue, $NaN
Variable operating expenses, $mNaN
Fixed operating expenses, $mNaN
Total operating expenses, $mNaN
Operating income, $mNaN
EBITDA, $mNaN
Interest expense (income), $mNaN
Earnings before tax, $mNaN
Tax expense, $mNaN
Net income, $mNaN

BALANCE SHEET

Cash and short-term investments, $mNaN
Total assets, $mNaN
Adjusted assets (=assets-cash), $mNaN
Average production assets, $mNaN
Working capital, $mNaN
Total debt, $mNaN
Total liabilities, $mNaN
Total equity, $mNaN
Debt-to-equity ratioNaN
Adjusted equity ratioNaN

CASH FLOW

Net income, $mNaN
Depreciation, amort., depletion, $mNaN
Funds from operations, $mNaN
Change in working capital, $mNaN
Cash from operations, $mNaN
Maintenance CAPEX, $mNaN
New CAPEX, $mNaN
Total CAPEX, $mNaN
Free cash flow, $mNaN
Issuance/(repurchase) of shares, $mNaN
Retained Cash Flow, $mNaN
Pot'l extraordinary dividend, $mNaN
Cash available for distribution, $mNaN
Discount rate, %NaN
PV of cash for distribution, $mNaN
Current shareholders' claim on cash, %NaN
HomeMenuAccount